We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

70 hedge funds and large institutions have $98.6M invested in Abeona Therapeutics in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,106% more call options, than puts

Call options by funds: $4M | Put options by funds: $95K

144% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 9

38% more capital invested

Capital invested by funds: $71.6M → $98.6M (+$27M)

21% more funds holding

Funds holding: 58 → 70 (+12)

0.1% more ownership

Funds ownership: 1.43% → 1.53% (+0.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 16

Holders
70
Holders Change
+12
Holders Change %
+20.69%
% of All Funds
1.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
13
Reduced
16
Closed
9
Calls
$4M
Puts
$95K
Net Calls
+$3.9M
Net Calls Change
+$3.87M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.33M
2
State Street
State Street
Massachusetts
+$1.62M
3
CHP
Castle Hook Partners
New York
+$1.36M
4
HCM
Highbridge Capital Management
New York
+$1.18M
5
Northern Trust
Northern Trust
Illinois
+$1.13M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.7M
2
OM
Opaleye Management
Massachusetts
-$1.38M
3
PA
Perceptive Advisors
New York
-$1.09M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$841K
5
NC
Nexthera Capital
New York
-$764K
Name Holding Trade Value Shares
Change 		Change in
Stake
WMSA
51
Weiss Multi-Strategy Advisers
New York
$64K +$54.6K +400 New
Simplex Trading
52
Simplex Trading
Illinois
$31K +$26.3K +193 +4,825%
Legal & General Group
53
Legal & General Group
United Kingdom
$23K +$19.4K +142 New
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$16.2K +$13.8K +101 New
CG
55
Cutler Group
California
$16K -$34.9K -256 -72%
MOACM
56
Mutual of America Capital Management
New York
$16K +$13.6K +100 New
Creative Planning
57
Creative Planning
Kansas
$14K – – –
AIP
58
Ameritas Investment Partners
Nebraska
$14K +$11.6K +85 New
GT
59
Glenmede Trust
Pennsylvania
$10K – – –
UBS Group
60
UBS Group
Switzerland
$10K +$8.46K +62 New
Barclays
61
Barclays
United Kingdom
$7K -$136K -998 -96%
Wells Fargo
62
Wells Fargo
California
$6K -$2.73K -20 -33%
LTFS
63
Ladenburg Thalmann Financial Services
Florida
$6K – – –
Royal Bank of Canada
64
Royal Bank of Canada
Ontario, Canada
$6K – – –
AG
65
Advisor Group
Arizona
$3K – – –
Citigroup
66
Citigroup
New York
$3K +$1.36K +10 +125%
TRCT
67
Tower Research Capital (TRC)
New York
$2K -$1.09K -8 -40%
Bank of America
68
Bank of America
North Carolina
$1K – – –
Northwestern Mutual Wealth Management
69
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Manulife (Manufacturers Life Insurance)
70
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K +$409 +3 +60%
Millennium Management
71
Millennium Management
New York
– -$1.7M -13,600 Closed
OM
72
Opaleye Management
Massachusetts
– -$1.38M -11,000 Closed
DCM
73
DAFNA Capital Management
California
– -$338K -2,701 Closed
LCM
74
Laurion Capital Management
New York
– -$277K -2,216 Closed
SCM
75
Segantii Capital Management
Hong Kong
– -$169K -1,356 Closed
1 2
3
4

ABEO Hedge Fund Activity: Q2 2017 in Review

70 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2017, worth a combined $98.6M — up 38% from $71.6M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ABEO positions and 9 closed out — a net gain of 13 holders — while 13 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $5.33M. The largest seller was Millennium Management, exiting entirely with an estimated $1.7M sold.

  • 70 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2017, up from 58 in Q1 2017.
  • Funds reported $98.6M of Abeona Therapeutics stock for Q2 2017, up 38% quarter-over-quarter.
  • 22 funds opened new Abeona Therapeutics positions in Q2 2017 and 9 closed out, a net change of +13 holders.
  • The largest Abeona Therapeutics buyer in Q2 2017 was BlackRock, an estimated $5.33M added.
  • The largest Abeona Therapeutics seller in Q2 2017 was Millennium Management, an estimated $1.7M sold.

Based on aggregated 13F filings for Q2 2017.